{
    "nctId": "NCT00909142",
    "briefTitle": "Bonefos and the Consumption of Analgesics",
    "officialTitle": "Bonefos and the Consumption of Analgesics. Influence of Clodronate on Analgesics Consumption Among Patients With Bone Metastasis",
    "overallStatus": "COMPLETED",
    "conditions": "Bone Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 149,
    "primaryOutcomeMeasure": "Analgesics consumption after 12 months of treatment with Bonefos in patients with bone metastases and breast or prostate cancer or multiple myeloma",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer or prostate cancer or multiple myeloma.\n* Bone metastasis.\n* Ability to use analgesics and clodronate 1600 mg/day.\n\nExclusion Criteria:\n\n* Hypersensitivity to bisphosphonates.\n* Clodronate in previous therapy.\n* Concomitant use of other bisphosphonates.\n* Serious renal insufficiency.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}